Rosa Ana Picazo González

Prof. Dr. Rosa Ana Picazo González

orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2004 in Domestic Animal Endocrinology
Verified
Journal Article
Closed access
JSJulián Santiago-Moreno
Julián Santiago-Moreno
ALA. López-Sebastián
A. López-Sebastián
ACA. del Campo
A. del Campo
AGA. González-Bulnes
A. González-Bulnes
RGRosa Ana Picazo González
Rosa Ana Picazo González
AGA. Gómez-Brunet
A. Gómez-Brunet

1 October 1996 in Cryobiology
Verified
Journal Article
Closed access
MCM.J. Cocero
M.J. Cocero
ASA.LOpez Sebastian
A.LOpez Sebastian
MBM.L. Barragan
M.L. Barragan
RGRosa Ana Picazo González
Rosa Ana Picazo González

1 November 2004 in Reproduction
Verified
Journal Article
Closed access
PDF file
RGRosa Ana Picazo González
Rosa Ana Picazo González
JRJ P García Ruiz
J P García Ruiz
JSJulián Santiago-Moreno
Julián Santiago-Moreno
AGAntonio Gonzalez-Bulnes
Antonio Gonzalez-Bulnes
JMJ MuñoZ
J MuñoZ
JIJ C Illera
J C Illera
The actions of prolactin (PRL) on target cells depend on the type of prolactin receptor (PRLr) predominantly expressed, particularly whether the long PRLr isoform is expressed. The aims of this study were to determine the cellular localization and the changes in expression of long and short PRLr isoforms in sheep ovary throughout the estrous cycle. Long and short PRLrs were localized mostly in the same ovarian cells. Maximum signal intensity, particularly for long PRLrs, was found in stromal cells surrounding primordial and primary follicles, and, for both PRLrs, in granulosa cells of preantral follicles and in luteal cells. Moderate signal intensity for PRLrs was found in theca cells of preantral to ovulatory follicles, and in granulosa cells of antral follicles up to the gonadotropin-dependent stage. Decreasing immunoreactivity to PRLrs was found in granulosa cells of gonadotropin-dependent to ovulatory follicles. For long PRLrs in particular, no signal was found in mural granulosa cells of gonadotropin-dependent follicles; for both isoforms, no signal was found in most granulosa cells of ovulatory follicles. In primordial to gonadotropin-dependent follicles, cellular localization of PRLr was similar on days 0, 10 and 15 of the cycle. Oocytes consistently showed positive immunostaining for PRLrs. Comparative RT-PCR analysis of long and short PRLr expression showed that the short isoform is evenly expressed throughout the estrous cycle, whereas the expression of the long form increases at the time of estrus and decreases at mid-luteal phase and at the onset of the follicular phase. Expression of long PRLrs was greater than that of short PRLrs on day 0 of cycle; expression of both isoforms was similar on day 10 and on day 15, long PRLrs expression was lower than that of short PRLrs. Our results indicate that in sheep ovary, the maximum responsiveness to PRL might occur during the preovulatory phase of the estrous cycle.

1 February 2005 in Animal Reproduction Science
Verified
Journal Article
Closed access
JSJulián Santiago-Moreno
Julián Santiago-Moreno
AGA. Gómez-Brunet
A. Gómez-Brunet
ATAdolfo Toledano
Adolfo Toledano
AGAntonio Gonzalez-Bulnes
Antonio Gonzalez-Bulnes
RGRosa Ana Picazo González
Rosa Ana Picazo González
ALA. López-Sebastián
A. López-Sebastián

1 June 1995 in Animal Reproduction Science
Verified
Journal Article
Closed access
ABA.Gómez Brunet
A.Gómez Brunet
ASA.López Sebastian
A.López Sebastian
RGRosa Ana Picazo González
Rosa Ana Picazo González
BCB. Cabellos
B. Cabellos
SGS. Goddard
S. Goddard

30 April 2024 in Animals
Verified
Journal Article
Open access
PDF file
RGRosa Ana Picazo González
Rosa Ana Picazo González
CRConcepción Rojo
Concepción Rojo
JRJesus Rodriguez-Quiros
Jesus Rodriguez-Quiros
AGAlfredo González Gil
Alfredo González Gil
Mesenchymal stem cells (MSCs) are considered a very promising alternative tool in cell therapies and regenerative medicine due to their ease of obtaining from various tissues and their ability to differentiate into different cell types. This manuscript provides a review of current knowledge on the use of MSC-based therapies as an alternative for certain common pathologies in dogs and cats where conventional treatments are ineffective. The aim of this review is to assist clinical veterinarians in making decisions about the suitability of each protocol from a clinical perspective, rather than focusing solely on research. MSC-based therapies have shown promising results in certain pathologies, such as spinal cord injuries, wounds, and skin and eye diseases. However, the effectiveness of these cell therapies can be influenced by a wide array of factors, leading to varying outcomes. Future research will focus on designing protocols and methodologies that allow more precise and effective MSC treatments for each case.